Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gossamer Bio Inc.

1.03
-0.0600-5.50%
Volume:620.47K
Turnover:651.58K
Market Cap:234.04M
PE:-4.12
High:1.10
Open:1.08
Low:1.03
Close:1.09
Loading ...

Gossamer Bio Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
13 May

Press Release: Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025

Dow Jones
·
13 May

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
08 May

Gossamer Bio Inc. to Present Preclinical Data on Seralutinib at American Thoracic Society International Conference

Reuters
·
08 May

Gossamer Bio Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
02 May

3 Promising Penny Stocks With Market Caps Over $100M

Simply Wall St.
·
26 Apr

Gossamer Bio Is Maintained at Buy by Goldman Sachs

Dow Jones
·
18 Apr

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

Insider Monkey
·
16 Apr

BRIEF-Gossamer Bio Announces Inducement Grant Under

Reuters
·
09 Apr

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
09 Apr

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Business Wire
·
09 Apr

Is Gossamer Bio Inc. (GOSS) the Popular Penny Stock on Robinhood to Watch?

Insider Monkey
·
27 Mar

Is Gossamer Bio, Inc. (GOSS) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Gossamer Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Mar

Gossamer Bio Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
14 Mar

Piper Sandler Sticks to Their Buy Rating for Gossamer Bio (GOSS)

TIPRANKS
·
14 Mar

Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
14 Mar

Gossamer Bio: Q4 Earnings Snapshot

Associated Press Finance
·
14 Mar

Gossamer Bio Q4 2024 GAAP EPS $(0.15) Beats $(0.17) Estimate, Sales $9.379M Beat $6.834M Estimate

Benzinga
·
14 Mar

BRIEF-Gossamer Bio Q4 EPS USD -0.15

Reuters
·
14 Mar